Human gingival fibroblasts are a source of B cell‐activating factor during periodontal inflammation

Abstract

AbstractBackgroundHost‐modulating therapy is a possible treatment for individuals that respond poorly to conventional periodontal therapy. B cells, abundant in periodontitis lesions, require the cytokines B cell‐activating factor (BAFF) and A proliferation‐inducing ligand (APRIL) for survival and maturation. Although mRNA levels of BAFF and APRIL are increased in tissue from periodontitis lesions, it is unknown if periodontal resident cells express BAFF and/or APRIL during periodontal inflammation. In this study, we aim to analyze the expression of BAFF and APRIL in human gingival fibroblasts after stimulation with proinflammatory cytokines. Furthermore, we perform protein analysis in tissues and serum from periodontitis patients and healthy controls.MethodsHuman gingival fibroblasts were cultured and stimulated with the proinflammatory cytokines’ tumor necrosis factor‐alpha (TNF‐α) and interleukin‐1 beta (IL‐1β). The mRNA expression of BAFF and APRIL was analyzed by real‐time quantitative polymerase chain reaction (qPCR), and the protein was detected in tissue sections using immune staining. Serum levels of BAFF were analyzed with enzyme‐linked immunosorbent assay (ELISA).ResultsIn gingival fibroblasts, TNF‐α upregulated BAFF mRNA, but APRIL was unaffected. IL‐1β affected neither BAFF nor APRIL expression. BAFF protein was detected in the oral epithelium and in cells of the underlying connective tissue in periodontitis tissue, and BAFF protein was increased in the serum of periodontitis patients.ConclusionPeriodontal resident cells express BAFF during periodontal inflammation and participate in providing a favorable milieu for the survival and action of B cells.